JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol.147, no.2, pp.520-531, 2021 (SCI-Expanded)
Background: There is uncertainty about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI), a population at risk of developing severe coronavirus disease 2019. This is relevant not only for these patients but also for the general population, because studies of IEIs can unveil key requirements for host defense.